Drug Testing and Analysis

Cover image for Vol. 10 Issue 1

Editor-in-Chief: Prof. Mario Thevis

Impact Factor: 3.469

ISI Journal Citation Reports © Ranking: 2016: 15/76 (Chemistry Analytical); 25/78 (Biochemical Research Methods); 62/257 (Pharmacology & Pharmacy)

Online ISSN: 1942-7611


Author Guidelines


For additional tools visit Author Resources - an enhanced suite of online tools for Wiley Online Library journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.



Author Guidelines


Download Instructions to Authors as PDF

General

Drug Testing and Analysis (DTA) is devoted to the publication of papers dealing with the development and application of techniques for the determination of controlled or controversial substances.

Papers must clearly be of scientific value in the field and will be submitted to two independent referees. Contributions must be in English and must not have been published elsewhere, and authors must agree not to communicate the same material for publication to any other journal. It is in the author's interest to ensure accurate and consistent presentation and thus avoid publication delays. There are no page charges.

The Editors are aware that restrictions may be enforced by certain agencies concerning the provision of comprehensive synthesis methods for controversial substances. Articles without comprehensive synthesis methodologies may be considered at the discretion of the Editor providing the scientific integrity of the article is not compromised. If affected, authors should state explicitly the reason for the omission in their covering letter together with a statement justifying the omission in the submitted article.

Return to Top

Manuscript Submission

All papers must be submitted via the online system. Drug Testing and Analysis operates an online submission and peer review system that allows authors to submit articles online and track their progress via a web interface. Please read the remainder of these instructions to authors and then click http://mc.manuscriptcentral.com/dta to navigate to the Drug Testing and Analysis online submission site.

IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have created an account.

File types. Preferred formats for the text and tables of your manuscript are .docx, .doc, .rtf, .ppt, .xls. LaTeX files may be submitted provided that an .eps or .pdf file is provided in addition to the source files. Figures may be provided in .tiff or .eps format.

INITIAL SUBMISSION

NON-LATEX USERS: Editable source files must be uploaded at this stage. Tables must be on separate pages after the reference list, and not be incorporated into the main text. Figures should be uploaded as separate figure files.

LATEX USERS: For reviewing purposes you should upload a single .pdf that you have generated from your source files. You must use the File Designation "Main Document" from the dropdown box.

REVISION SUBMISSION

NON-LATEX USERS: Editable source files must be uploaded at this stage. Tables must be on separate pages after the reference list, and not be incorporated into the main text. Figures should be uploaded as separate figure files.

LATEX USERS: When submitting your revision you must still upload a single .pdf that you have generated from your now revised source files. You must use the File Designation "Main Document" from the dropdown box. In addition you must upload your TeX source files. For all your source files you must use the File Designation "Supplemental Material not for review". Previous versions of uploaded documents must be deleted. If your manuscript is accepted for publication we will use the files you upload to typeset your article within a totally digital workflow.

USING OVERLEAF

Wiley has partnered with Overleaf, a collaborative, cloud-based authoring tool to offer you Overleaf Link on DTA. With Overleaf Link you have a dedicated article submission template, where you can write and edit your article in Overleaf and then submit directly to the journal editorial office.

The article submission template is available here

For more information, please visit our Overleaf Link webpage.

If you are new to Overleaf there are a number of video tutorials available at this link

If you need any help, we have a direct support arrangement with Overleaf. Please contact them at support@overleaf.com or visit www.overleaf.com/contact.

Return to Top

Accepted Articles

'Accepted Articles' have been accepted for publication and undergone full peer review but have not been through the copyediting, typesetting, pagination and proofreading process. Accepted Articles are published online a few days after final acceptance, appear in PDF format only (without the accompanying full-text HTML) and are given a Digital Object Identifier (DOI), which allows them to be cited and tracked. The DOI remains unique to a given article in perpetuity. More information about DOIs can be found online at http://www.doi.org/faq.html. Given that Accepted Articles are not considered to be final, please note that changes will be made to an article after Accepted Article online publication, which may lead to differences between this version and the Version of Record.

The Accepted Articles service has been designed to ensure the earliest possible circulation of research papers after acceptance.

Accepted articles will be indexed by PubMed; Therefore the submitting author must carefully check the names and affiliations of all authors provided in the cover page of the manuscript, as it will not be possible to alter these once a paper is made available online in Accepted Article format. Subsequently the final copyedited and proofed articles will appear either as Early View articles in a matter of weeks or in an issue on Wiley Online Library; the link to the article in PubMed will automatically be updated.

Return to Top

Copyright and Permissions

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement

If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:

CTA Terms and Conditions http://exchanges.wiley.com/authors/faqs---copyright-_301.html

For authors choosing OnlineOpen

If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

Creative Commons Attribution License OAA

Creative Commons Attribution Non-Commercial License OAA

Creative Commons Attribution Non-Commercial -NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://exchanges.wiley.com/authors/faqs---copyright-_301.html and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

If you select the OnlineOpen option and your research is funded by certain funders [e.g. The Wellcome Trust and members of the Research Councils UK (RCUK) or the Austrian Science Fund (FWF)] you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.

Return to Top

English Editing

Papers must be in English. Oxford English Dictionary or American spelling is acceptable, provided usage is consistent within the manuscript.

Manuscripts that are written in English that is ambiguous or incomprehensible, in the opinion of the Editor, will be returned to the authors with a request to resubmit once the language issues have been improved. This policy does not imply that all papers must be written in "perfect" English, whatever that may mean. Rather, the criterion will require that the intended meaning of the authors must be clearly understandable, i.e., not obscured by language problems, by referees who have agreed to review the paper.

Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English. A list of independent suppliers of editing services can be found at http://www.blackwellpublishing.com/bauthor/english_language.asp Japanese authors can also find a list of local English improvement services at http://www.wiley.co.jp/journals/editcontribute.html All services are paid for and arranged by the author, and use of one of these services does not guarantee acceptance or preference for publication.

Return to Top

Presentation of papers

Manuscript style. Use a standard font of the 12-point type: Times, Helvetica, or Courier is preferred. It is not necessary to double-line space your manuscript.

Tables must be on separate pages after the reference list, and not be incorporated into the main text. Figures should be uploaded as separate figure files.

  • During the submission process you must enter 1) the full title 2) the short title of up to 70 characters 3) names and affiliations of all authors and 4) the full address, including email, telephone and fax of the author who is to check the proofs.
  • Include the name(s) of any sponsor(s) of the research contained in the paper, along with grant number(s) and details of any conflicts of interest, be they personal, commercial, political, academic or financial.
  • Enter an abstract of no more than 250 words for all articles. Please see the guidance below on acceptable abstract writing for DTA
  • Keywords. Authors should prepare no more than 5 keywords for their manuscript.

Return to Top

Writing Abstracts

An abstract is a concise summary of the whole paper, not just the conclusions. The abstract should be no more than 250 words and convey the following:

1. An introduction to the work. This should be accessible by scientists in any field and express the necessity of the experiments executed

2. Some scientific detail regarding the background to the problem

3. A summary of the main result

4. The implications of the result

5. A broader perspective of the results, once again understandable across scientific disciplines

It is crucial that the abstract convey the importance of the work and be understandable without reference to the rest of the manuscript to a multidisciplinary audience. Abstracts should not contain any citation to other published works.

Reference Style

All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. All references must be complete and accurate. If necessary, cite unpublished or personal work in the text but do not include it in the reference list. Where possible the DOI * for the reference should be included at the end of the reference. Online citations should include date of access. References should be listed in the following style:

Journal article (1-6 authors)
1. Hu P, Reuben DB. Effects of managed care on the length of time that elderly patients spend with physicians during ambulatory visits. Med Care 2002;40(7):606-613.

Journal article with more than six authors
2. Geller AC, Venna S, Prout M, et al. Should the skin cancer examination be taught in medical school? Arch Dermatol 2002;138(9):1201-1203.

Journal article with no named author or group name
3. Centers for Disease Control and Prevention (CDC). Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use--Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 2010;59(9):273.

Electronic Journal article
If you have a doi (preferred):
4. Gage BF, Fihn SD, White RH. Management and dosing of warfarin therapy. The American Journal of Medicine 2000;109(6):481-488. doi:10.1016/S0002-9343(00)00545-3.

If you do not have a doi:
5. Aggleton JP. Understanding anterograde amnesia: disconnections and hidden lesions. Q J Exp Psychol 2008;61(10):1441-1471. http://search.ebscohost.com/login.aspx?direct=true&db=pbh&AN=34168185&site=ehost-live Accessed March 18, 2010.

Entire Book
6. McKenzie BC. Medicine and the Internet: Introducing Online Resources and Terminology. 2nd ed. New York, NY: Oxford University Press; 1997.

Book Chapter
7. Guyton JL, Crockarell JR. Fractures of acetabulum and pelvis. In: Canale ST, ed. Campbell's Operative Orthopaedics. 10th ed. Philadelphia, PA: Mosby, Inc; 2003:2939-2984.

Electronic Book
8. Rudolph CD, Rudolph AM. Rudolph's Pediatrics. 21st ed. New York, NY: McGraw-Hill Companies; 2002. http://online.statref.com/Document/Document.aspx?DocID=1&StartDoc=1&EndDoc=1882&FxID=13&offset=7&SessionId=A3F279FQVVFXFSXQ . Accessed August 22, 2007.

Internet Document
9. American Cancer Society. Cancer Facts & Figures 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Accessed March 3, 2003.

Please note that journal title abbreviations should conform to the practices of Chemical Abstracts. For more information about AMA reference style - AMA Manual of Style

*The Digital Object Identifier (DOI) is an identification system for intellectual property in the digital environment. Developed by the International DOI Foundation on behalf of the publishing industry, its goals are to provide a framework for managing intellectual content, link customers with publishers, facilitate electronic commerce, and enable automated copyright management.

Illustrations and ChemDraw Rules

Upload each figure as a separate file in either .tiff or .eps format, with the figure number and the top of the figure indicated. Compound figures e.g. 1a, b, c should be uploaded as one figure. Tints are not acceptable. Lettering must be of a reasonable size that would still be clearly legible upon reduction, and consistent within each figure and set of figures. Where a key to symbols is required, please include this in the artwork itself, not in the figure legend. All illustrations must be supplied at the correct resolution:

  • Black and white and colour photos - 300 dpi
  • Graphs, drawings, etc - 800 dpi preferred; 600 dpi minimum
  • Combinations of photos and drawings (black and white and colour) - 500 dpi

Tables should be part of the the main document and should be placed after the references. If the table is created in excel the file should be uploaded separately.

Chemical structures should be prepared in ChemDraw either 80mm (onecolumn)or175mm (twocolumn) widths. However, the one-column format should be used whenever possible as this allows greater flexibility in the layout of the manuscript.Use this ChemDraw Download or use the following settings:

Drawing settingsText settings
chain angle120°fontArial
bond spacing18% of lengthsize12 pt
fixed length17 pt
bond width2 ptPreferences
line width0.75 ptunitspoints
margin width2 pttolerances5 pixels
hash spacing2.6 pt
Bold width2.6 pt

Authors using different structural drawing programs should choose settings consistent with those above. Compound numbers should be bold, but not atom labels or captions.


Return to Top

Graphical Table of Contents

DTA’s table of contents will be presented in graphical form with a brief abstract.

The table of contents entry must include the article title, the authors' names (with the corresponding author indicated by an asterisk), no more than 80 words or 3 sentences of text summarising the key findings presented in the paper and a figure that best represents the scope of the paper. (see the section on abstract writing for more guidance).

Table of contents entries should be submitted to Manuscript Central in one of the generic file formats and uploaded as ‘Supplementary material for review’ during the initial manuscript submission process.

The image supplied should fit within the dimensions of 50mm x 60mm, and be fully legible at this size.

Examples for arranging the text and figures as well as paper title and authors' names are shown below.

sample figure

Return to Top

Supporting Information

Supporting Information can be a useful way for an author to include important but ancillary information with the online version of an article. Examples of Supporting Information include additional tables, data sets, figures, movie files, audio clips, 3D structures, and other related nonessential multimedia files. Supporting Information should be cited within the article text, and a descriptive legend should be included. It is published as supplied by the author, and a proof is not made available prior to publication; for these reasons, authors should provide any Supporting Information in the desired final format. For further information on recommended file types and requirements for submission, please visit: http://authorservices.wiley.com/bauthor/suppinfo.asp

Return to Top

Colour policy

Colour is free of charge for authors submitting the following article types:

• Review

• Mini-review

• Tutorial

• Perspective

• Annual Banned-Substance Review

The cost of printing colour illustrations for Research Articles may be charged to the author however they may feature in colour on-line free of charge. For colour charge scales please contact Journals Production

Return to Top

Citing EarlyView Articles

To include the DOI in a citation to an article, simply append it to the reference as in the following example:

R. K. Harris, A. Nordon, K. D. M. Harris, Rapid. Commun. Mass Spec. 2007, DOI: 10.1002/rcm.21464.

To link to an article from the author’s homepage, take the DOI (digital object identifier) and append it to "http://dx.doi.org/" as per following example:

DOI 10.1002/DTA.20941, becomes http://dx.doi.org/10.1002/DTA.20941.

Return to Top

Conventions adopted by DTA

Nomenclature. Authors should conform to nomenclature, symbols, abbreviations and procedures adopted by ASTM. SI units are preferred; if more commonly used units are adopted, conversion factors should be given at their first occurrence.

Description of Experimental Methods. The Experimental section should be precise and give all details necessary for repeating the work. Particular attention should be given to methods used for calibration of instruments and spectra when electron spectroscopic data are presented.

Abbreviations. All abbreviations should be defined the first time they are used.

Ethical Guidance.DTA requires that the conditions under which human and animal experiments are performed are consistent with recognised standards. Authors must make it clear that the procedures they used were as humane as possible and complied with the guidelines for animal care of their institutions or with national/international guidelines. Studies involving human subjects must be carried out with the formal approval of the relevant Ethical Committee, and evidence of such approval must be provided on request.

Return to Top

Article formats published in DTA

  • Annual Banned-Substance Review
  • Tutorial
  • Review
  • Mini-review
  • Cornerstone Articles
  • Perspective
  • Research Article
  • Application Notes
  • Short Communications
  • Case report/letters
  • Current Awareness
  • Podcast/Webinar
  • Errata

Annual Banned-Substance Review. This annual review will provide an in depth critique of popular known banned substances and assess and review the current state of detection methods. The annual banned substance review will be coordinated by the journal editors and published annually in the first issue of each volume. Authors inclined to contribute may contact the Editor in Chief. Example article: http://onlinelibrary.wiley.com/doi/10.1002/dta.1769/epdf

Tutorials. Tutorial Articles provide a source of information that goes beyond that conveyed in a normal research article. Topics should be presented at an introductory level suitable for non-experts with maximum attention being given to clarity of expression, freedom from jargon, and high quality figures. Articles should stimulate as well as inform the readers. Tutorials must be accompanied by an abstract and contain less than 50 references.

Reviews. Reviews should offer a broad and accessible précis of a topic. There are no formal limits on article length but they should typically contain in excess of 70 references. Reviews are encouraged and may be submitted without prior consultation with the Editors.

Mini-reviews. The criteria for a mini review is the same as a full critical review albeit less extensive in length and scope. Mini-reviews contain no more than 50 references.

Cornerstone Articles. Cornerstone papers are an occasional article type bringing previously published seminal work to the attention of the Drug Testing and Analysis audience. Such features may include previously unavailable English translations of influential research or pioneering articles from complimentary disciplines that have made a significant contribution to the field of drug testing.

Perspectives. A Perspective is a lightly referenced scholarly opinion piece about current or future directions in a field. A Perspective can serve to assess the science directly concerned with a particular topic or report on relevant issues that may arise from the discipline (for example, policy, effects on society, regulatory issues and controversies). Perspectives that address interdisciplinary research areas or experimental results with significance to a broader audience are of particular interest to the Editors. The Perspective does not have an abstract and generally contain less than 50 references. Perspectives will be subject to screening for appropriateness and accuracy but will not undergo the traditional peer review model.

Research Articles. There are no formal limits on the page extent for Research Articles. Please see the above section for rules pertaining to format and presentation.

Application notes. Short articles reporting on innovative applications, "kitchen tips" from a laboratory setting or technology. Application notes in DTA are not advertorials but are welcomed from both product manufacturers and independent authors. DTA recommends for conciseness that each Application note is written in an accessible, easy-to-read style, less than 3 journal pages in length including illustrations (approx 2000 words including 3 illustrations) and contain less than 20 references. Application Notes will be screened for scientific accuracy and appropriateness.

Short communications. Short papers containing important, new, definitive information of sufficient significance to warrant publication may be submitted to the journal as a Short Communication. These submissions should be concise, representing either a preliminary report or a complete account of a significant, short research contribution. Technique or methods papers may also be accepted in this category. The submitted paper should be less than 2000 words with a maximum combination of five figures and/or tables, and a maximum of 20 references.

Case reports/Letters. Case reports and letters to the editor will publish under the category of Correspondence and must not contain more than 20 references. Articles in this category will be subject to screening for scientific accuracy but will not undergo traditional peer review models, they require no accompanying abstract.

Podcast/webinars. DTA will supplement the traditional publishing models by providing its audience with Podcasts and Webinars. Descriptions of these methods of dissemination can be found on Wikipedia.

Podcast

Webinar

The editors invite authors to participate in this initiative. Proposals can be sent directly to the Wiley journal editor for consideration. ptrevorr@wiley.com. Note: these materials will be monitored for scientific accuracy but will not undergo the traditional processes of peer review.

Errata. Corrections should be presented together with the full bibliographic information of the target article. Errata should be emailed directly to the Editor in Chief.

Return to Top

Cover Artwork Opportunities

Drug Testing and Analysiswill feature a cover graphic for the purpose of highlighting an article featured within the issue. Authors wishing to explore this opportunity are advised to supply a suitable illustration for this purpose. The selection process for cover illustrations will be the determined by the Editors.

Cover image

Return to Top

Please note that you must own the copyright to reproduce images, if you do not own the images then permission must be granted by the copyright holder.

Reproductions of the cover in print and electronic formats and additional copies of the journal featuring bespoke cover artwork may be obtained from the publisher. Please direct any enquiries to ptrevorr@wiley.com

Further Information

For accepted manuscripts the publisher will supply proofs to the submitting author prior to publication. This stage is to be used only to correct errors that may have been introduced during the production process. Prompt return of the corrected proofs, preferably within two days of receipt, will minimise the risk of the paper being held over to a later issue. Offprints and copies of the journal may be ordered. There is no page charge to authors.

Manuscript accepted for publication? If so, check out our suite of tools and services for authors and sign up for:

  • Article Tracking
  • E-mail Publication Alerts
  • Personalization Tools

SEARCH

SEARCH BY CITATION